GVK BIO recognized by the Central Board of Indirect Taxes and Customs as an “Authorised Economic Operator”

Hyderabad, India – December 13, 2018: GVK BIO, a leading Contract Research and Development Organisation (CRDO), today announced that it has been recognised by the Central Board of Indirect Taxes and Customs as an “Authorised Economic Operator” with a T1 Certification for a period of two years as ‘secure’ and ‘reliable’ trade partner. GVK BIO has been appreciated and recognised for its commitment to secure the international supply chain and in compliance with World Customs Organizations (WCO) framework of Standards to Secure and Facilitate Global Trade (SAFE Framework).

Paresh Gupta, Chief Financial Officer,  GVK BIO said, “The AEO certification furthers GVK BIO’s commitment  to accelerate our customers R&D programs. This certification will help us reduce discovery cycle time and cost considerably.”

About GVK BIO

GVK BIO, a leading Contract Research & Development Organization (CRDO) that services the global Biopharma industry; is headquartered in Hyderabad, India with operations in four sites including California, USA. Established in 2001, GVK BIO has over 17 years of rich experience across the Research and Development value chain with a focus on speed and quality. Our team of over 2000 highly qualified scientists, backed by well-defined and scalable processes, modern facilities and a strong customer-centric partnering approach, focus on bringing our customers’ products to market.

 

For further information, please contact:

Email: corpcomm@gvkbio.com

Phone: +91 40 6628 1822

© 2019 | GVK Biosciences Private Limited, All Rights Reserved | Terms & Conditions | Privacy Policy | Privacy Notice - Customers/Vendors/Job Applicants

Log in with your credentials

Forgot your details?